Intranasal and oral cocaine kinetics
- PMID: 7357795
- DOI: 10.1038/clpt.1980.52
Intranasal and oral cocaine kinetics
Abstract
Plasma cocaine levels were determined in 7 subjects after intranasal and oral cocaine. Intranasal doses of 0.19, 0.38, 0.75, 1.5, and 2.0 mg/kg were given as a 10% aqueous solution; 0.38 mg/kg was given as crystalline cocaine HCl. Oral cocaine was administered in doses of 2.0 and 3.0 mg/kg. Intranasal cocaine kinetics were described by a 1-compartment open model with 2 consecutive first-order input steps and first-order elimination. Oral cocaine disposition was described by a 1-compartment open model with a lag time followed by a single first-order input phase and first-order elimination. The mean elimination half-life (t 1/2) for cocaine by the intranasal route to 7 subjects was 75 +/- 5 min (mean +/- SE). The mean t 1/2 after oral administration to 4 subjects was 48 +/- 3 min. The relative bioavailability [as determined by the area under the concentration-time curve (AUC)] for the 2.0-mg/kg dose by the intranasal and oral routes was not different. There was a linear increase in AUC with increasing intranasal dose.
Similar articles
-
Kinetics of cocaine in humans after intravenous and intranasal administration.Biopharm Drug Dispos. 1983 Jan-Mar;4(1):9-18. doi: 10.1002/bdd.2510040104. Biopharm Drug Dispos. 1983. PMID: 6839006
-
Cocaine plasma concentration: relation to physiological and subjective effects in humans.Science. 1978 Oct 13;202(4364):227-8. doi: 10.1126/science.694530. Science. 1978. PMID: 694530
-
[Cocaine contact anesthesia for endonasal surgery. Kinetics and clinical tolerance of a concentrated solution].Ann Fr Anesth Reanim. 1995;14(6):472-7. doi: 10.1016/s0750-7658(05)80487-3. Ann Fr Anesth Reanim. 1995. PMID: 8745970 French.
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
-
Clinical pharmacokinetics of intranasal sumatriptan.Clin Pharmacokinet. 2002;41(11):801-11. doi: 10.2165/00003088-200241110-00002. Clin Pharmacokinet. 2002. PMID: 12190330 Review.
Cited by
-
Topical Cocaine Hydrochloride Nasal Solution: Anesthetic and Surgical Considerations.Cureus. 2023 Aug 1;15(8):e42804. doi: 10.7759/cureus.42804. eCollection 2023 Aug. Cureus. 2023. PMID: 37664274 Free PMC article. Review.
-
Improved performance 4 hours after cocaine.Psychopharmacology (Berl). 1993;110(4):415-20. doi: 10.1007/BF02244647. Psychopharmacology (Berl). 1993. PMID: 7870911 Clinical Trial.
-
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.Exp Clin Psychopharmacol. 2009 Aug;17(4):205-16. doi: 10.1037/a0016469. Exp Clin Psychopharmacol. 2009. PMID: 19653786 Free PMC article. Clinical Trial.
-
Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.J Anal Toxicol. 2018 Jun 1;42(5):285-292. doi: 10.1093/jat/bky007. J Anal Toxicol. 2018. PMID: 29462364 Free PMC article.
-
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users.Br J Pharmacol. 2013 Dec;170(7):1410-20. doi: 10.1111/bph.12425. Br J Pharmacol. 2013. PMID: 24106872 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources